16 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
18 Oct 23
Current report (foreign)
6:20am
. Products Approved in FY 2021: Regenerative Medical Products. Available at: https://www.pmda.go.jp/files/000247822.pdf. Last accessed October 2023. 7. Phase 3
6-K
EX-99.1
5cx0btk1rpjt 3dimtzb
21 Nov 19
Current report (foreign)
6:08am
6-K
EX-99.1
hpkz z2z7n9
14 Nov 19
Current report (foreign)
6:26am
424B3
jky6kb9v j5e0g67t
14 Nov 19
Prospectus supplement
6:10am
F-4/A
p48tdsarnuq5lr31hp
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
1mgld3y0juabw
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
z8hc8gyv67 fu
27 Jun 19
Annual report (foreign)
6:41am
6-K
ifl1 f3oafrw6g5qg
30 May 19
Current report (foreign)
10:26am
6-K
xauh8aa
4 Feb 19
Current report (foreign)
6:07am
20FR12B/A
wv0h1
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
5ogasa6p
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
n5q9u
16 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next